MACROGENICS INC|4Feb 17, 6:27 PM ET

Bonvini Ezio 4

4 · MACROGENICS INC · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 17, 2026

MACROGENICS (MGNX) Sr VP Ezio Bonvini Exercises Derivatives, Receives RSUs

What Happened

Ezio Bonvini, Senior Vice President, Research & CSO of MacroGenics (MGNX), had derivative instruments converted/exercised and was granted restricted stock units (RSUs). On Feb 15, 2026 he exercised/converted 16,665 derivative shares and, to satisfy tax withholding, 6,433 shares were surrendered/withheld (reported value $11,000 at $1.71 per share). On Feb 12, 2026 the filing reports new/recognized RSU grants of 31,250 and 187,500 shares (derivative awards reported at $0.00).

Key Details

Transaction dates: Feb 12, 2026 (RSU grants); Feb 15, 2026 (exercise/conversion and tax withholding).
Exercise/conversion reported: 16,665 derivative shares (reported as both acquired and disposed in the filing entries).
Tax withholding: 6,433 shares withheld/ surrendered at $1.71 per share, totaling $11,000 (transaction code F).
RSU grants: 31,250 and 187,500 RSUs reported on Feb 12, 2026 (reported as awards, code A, $0.00 per share).
Footnotes: prior RSU grant (Feb 15, 2023) of 50,000 RSUs vests in three equal annual installments; RSUs convert one-for-one to common stock; another footnote describes a vesting/ exercise cadence (12.5% then 6.25% quarterly).
Shares owned after the transactions: not specified in the provided filing extract.
Filing date: Feb 17, 2026 (appears timely relative to reported transaction dates).

Context

The sequence (exercise/conversion plus withholding of shares to cover taxes) is consistent with a cashless/net settlement or tax withholding on a stock-based award rather than an open-market sale. RSU awards are compensatory and vest over time per the footnotes; they do not by themselves indicate a buy/sell signal. The withheld shares relate to tax obligations, not a discretionary sale for cash.

Form 4

Period: 2026-02-12

Sr VP, Research & CSO

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-15+16,665→ 152,232 total
Tax Payment
Common Stock
2026-02-15$1.71/sh−6,433$11,000→ 145,799 total
Exercise/Conversion
Restricted Stock Unit
[F1]
2026-02-15−16,665→ 0 total
→ Common Stock (16,665 underlying)
Award
Restricted Stock Unit
[F2]
2026-02-12+31,250→ 31,250 total
→ Common Stock (31,250 underlying)
Award
Employee Stock Option (right to buy)
[F3]
2026-02-12+187,500→ 187,500 total
Exercise: $1.71Exp: 2036-02-12→ Common Stock (187,500 underlying)

Footnotes (3)

[F1]On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
[F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
[F3]12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Signature

/s/ Beth A. Smith, Attorney-in-fact|2026-02-17

1 file